Gentamicin Sulphate Release from Bioactive Ceramic Calcium Silicates

Abstract

Gentamicin sulphate was mixed with two different sol-gel derived calcium silicates (akermanite or wollastonite). Each of the mixtures was isostatically pressed. Samples were immersed in simulated body fluid for 21 days. The presence of the antibiotic showed no effect on the in vitro bioactivity of the ceramics. For evaluating the gentamicin sulphate release, samples were immersed in a phosphate buffered saline solution for different periods of time. Most of the gentamicin sulphate was released during the first 7 days. However, akermanite showed a lower antibiotic release rate than that observed for wollastonite.

The Effect of Different Substitutions (Cobalt, Copper, Strontium and Zinc) on the Properties of Akermanite Bioceramic: A Comparative Experimental Study

“…Akermanite (Ca 2 MgSi 2 O 7 ) as a Mg-, Ca-, Si-based bioceramic is more bioactive and have faster new bone formation ability in vivo, and degradation rate than that of β-TCP [3]. Mg, Ca, Si-based bioceramics can be used as bone substitute [4], coating for metallic implants [5,6,7], reinforcement of polymeric biomaterials [8,9], drug delivery [10,11] and porous scaffolds [12,13].…”